NL190266B - Aminozuuroplossing voor kankerpatienten. - Google Patents

Aminozuuroplossing voor kankerpatienten.

Info

Publication number
NL190266B
NL190266B NLAANVRAGE7906620,A NL7906620A NL190266B NL 190266 B NL190266 B NL 190266B NL 7906620 A NL7906620 A NL 7906620A NL 190266 B NL190266 B NL 190266B
Authority
NL
Netherlands
Prior art keywords
acid solution
cancer patients
aminoic acid
aminoic
cancer
Prior art date
Application number
NLAANVRAGE7906620,A
Other languages
English (en)
Other versions
NL190266C (nl
NL7906620A (nl
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NL7906620A publication Critical patent/NL7906620A/nl
Publication of NL190266B publication Critical patent/NL190266B/nl
Application granted granted Critical
Publication of NL190266C publication Critical patent/NL190266C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
NLAANVRAGE7906620,A 1978-09-04 1979-09-04 Aminozuuroplossing voor kankerpatienten. NL190266C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10874978 1978-09-04
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (3)

Publication Number Publication Date
NL7906620A NL7906620A (nl) 1980-03-06
NL190266B true NL190266B (nl) 1993-08-02
NL190266C NL190266C (nl) 1994-01-03

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7906620,A NL190266C (nl) 1978-09-04 1979-09-04 Aminozuuroplossing voor kankerpatienten.

Country Status (10)

Country Link
JP (1) JPS5535049A (nl)
AU (1) AU526207B2 (nl)
CA (1) CA1134275A (nl)
CH (1) CH642541A5 (nl)
DE (1) DE2935709C2 (nl)
FR (1) FR2434622A1 (nl)
GB (1) GB2029220B (nl)
IT (1) IT1194844B (nl)
NL (1) NL190266C (nl)
SE (1) SE448679B (nl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0076841A4 (en) * 1981-04-17 1984-01-16 American Hospital Supply Corp IMPROVED SOLUTION FOR PARENTERAL NUTRITION.
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
DE3329253A1 (de) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (fr) * 1985-12-19 1988-11-10 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
EP0560989B1 (en) * 1991-10-07 1999-09-01 Otsuka Pharmaceutical Factory, Inc. Enteral preparation for cancer therapy
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
DE4228897A1 (de) * 1992-08-29 1994-03-03 Wella Ag Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
DK0668933T3 (da) * 1992-11-19 2003-02-10 Anticancer Inc Anvendelse af methioninase som antitumormiddel i antimethioninkemoterapi
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
EP0921794A1 (en) * 1996-07-30 1999-06-16 Novartis Nutrition AG Amino acid composition and use thereof in treating tumor growth and metastasis
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
PT1163904E (pt) * 2000-06-16 2006-07-31 Rath Matthias Composicao para a prevencao de doencas do musculo liso, compreendendo ascorbato, arginina e magnesio
DE60028376T2 (de) * 2000-10-09 2007-06-06 Rath, Matthias, Dr. Therapeutische Kombination des Ascorbats mit Lysin und Arginin für Verhinderung und Behandlung des Krebses
CH694549A5 (de) 2001-01-16 2005-03-31 Dr Matthias Rath Verwendung einer synergistischen Zusammensetzung, die Ascorbat und Lysin für Zustände enthält zur Behandlung extrazellularer Matrixdegeration.
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
JPWO2003030890A1 (ja) * 2001-10-05 2005-02-10 哲朗 浅尾 免疫系活性化剤
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
EP1734819A1 (en) * 2004-03-19 2006-12-27 Pro-Pharmaceuticals, Inc. Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
US8580750B2 (en) * 2005-07-29 2013-11-12 Tima Foundation Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
WO2007016953A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
EP2156188B1 (en) 2007-03-28 2021-05-05 University of Southern California Induction of differential stress resistance and uses thereof
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
CA3045883C (en) * 2008-04-24 2022-06-28 University Of Southern California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
EP2676664B1 (en) * 2011-02-17 2017-06-21 EA Pharma Co., Ltd. Potentiator of antitumor activity of chemotherapeutic agent
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IL296055A (en) 2017-08-14 2022-10-01 Axcella Health Inc Amino acid compounds for the treatment of liver disease
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT297935B (de) * 1968-05-09 1972-04-10 Astra Ab Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen
SU423304A3 (nl) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (de) * 1970-03-19 1981-01-29 Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen Mittel zur Behandlung und Verhütung von Leberkrankheiten und muskulärer Insuffizienz
DE2530246A1 (de) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2531204A1 (de) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung

Also Published As

Publication number Publication date
SE7907316L (sv) 1980-03-05
JPS6154007B2 (nl) 1986-11-20
FR2434622B1 (nl) 1983-04-15
AU526207B2 (en) 1982-12-23
GB2029220A (en) 1980-03-19
AU5036879A (en) 1980-03-13
NL190266C (nl) 1994-01-03
FR2434622A1 (fr) 1980-03-28
CH642541A5 (de) 1984-04-30
NL7906620A (nl) 1980-03-06
GB2029220B (en) 1983-03-30
CA1134275A (en) 1982-10-26
SE448679B (sv) 1987-03-16
JPS5535049A (en) 1980-03-11
IT1194844B (it) 1988-09-28
DE2935709A1 (de) 1980-03-13
IT7905216A0 (it) 1979-09-03
DE2935709C2 (de) 1986-02-06

Similar Documents

Publication Publication Date Title
NL190266B (nl) Aminozuuroplossing voor kankerpatienten.
NO791140L (no) Tioetiansyrederivater.
NO792420L (no) Hudpleiepreparat.
NL7804974A (nl) 2-penem-3-carbonzuurverbindingen.
NL184722C (nl) Meercomponentencapsule voor tandtechnische doeleinden.
NO153205C (no) Tannrensemiddel.
NL7903077A (nl) Magnetische gordel voor medische doeleinden.
NL7808503A (nl) Cycloalkylideenmethylfenylazijnzuurverbindingen.
NL7901106A (nl) Werkwijze voor toepassing van werp-strooi-inrichtingen.
NL7809664A (nl) Werkwijze voor de bereiding van een huidontsmettings- zalf.
NL7903394A (nl) Medisch aggregaat.
NL188645C (nl) 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten.
FI790404A (fi) Farmaceutiska sammansaettningar
IT7924830A0 (it) Procedimento per preparare isopropenil-fenolo.
NL7904111A (nl) Houder voor bloed.
IT1164927B (it) Catodo per elettrolizzatori
NL184516C (nl) Werkwijze voor de bereiding van zouten van pyrodruivenzuur.
NL7901760A (nl) Wegwerpurinaal.
NL7901220A (nl) Digesubstitueerde-3-cefem-4-carbonzuurverbindingen en werkwijzen ter bereiding daarvan.
NL7902730A (nl) Ziekenbed.
NL7901453A (nl) Gesubstitueerd imidazolidinyl-3-chloor-3-cephem-4-car- bonzuur.
NL178002C (nl) Werkwijze voor de bereiding van di-n-propylazijnzuur.
NL7812598A (nl) Thioalkanoylalkaancarbonzuurverbindingen.
NL7901293A (nl) Plaveisteen.
NL7901290A (nl) Farmaceutische preparaten.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
A85 Still pending on 85-01-01
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 19990904